Danielle Hammond

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 14

Top Topics

Acute Myeloid Leukemia

Inflammatory Response

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yue Wei, Hong Zheng, Ziyi Li, Pamela Pennington Lockyer, Faezeh Darbaniyan, Rashmi Kanagal-Shamana, Hui Yang, Danielle Hammond, Guillermo Garcia Manero
Downregulation of UBA1 expression in myelodysplastic neoplasm. Leukemia (2024)
Guillermo Montalban Bravo, Juan Jose Rodriguez-Sevilla, David Michael Swanson, Rashmi Kanagal-Shamana, Danielle Hammond, Kelly Sharon Chien, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop M Kantarjian, Guillermo Garcia Manero
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia 38 (5) (2024)
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, Kelly Sharon Chien, Samuel Urrutia, Alexandre Bazinet, Juan Jose Rodriguez-Sevilla, Danielle Hammond, Koiji Sasaki, Koichi Takahashi, Courtney D D DiNardo, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban Bravo
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Blood advances 8 (11) (2024)
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, Kelly Sharon Chien, Samuel Urrutia, Alexandre Bazinet, Juan Jose Rodriguez-Sevilla, Danielle Hammond, Koiji Sasaki, Koichi Takahashi, Courtney D D DiNardo, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban Bravo
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Blood advances 8 (11) (2024)
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza-Huante, Kelly Sharon Chien, Samuel Urrutia, Alexandre Bazinet, Juan Jose Rodriguez-Sevilla, Danielle Hammond, Koiji Sasaki, Koichi Takahashi, Courtney D D DiNardo, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban Bravo
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Blood advances 8 (11) (2024)
Warren Fiskus, Jessica Piel, Michael P Collins, Murphy Hentemann, Branko Cuglievan, Christopher P Mill, Christine Birdwell, Kaberi Das, John A Davis, Hanxi Hou, Antrix Jain, Anna Malovannaya, Tapan M Kadia, Naval G Daver, Koiji Sasaki, Koichi Takahashi, Danielle Hammond, Patrick K Reville, Jian Wang, Sanam Loghavi, Rwik Sen, Xinjia Ruan, Xiaoping Su, Lauren B Flores, Courtney D D DiNardo, Kapil N Bhalla
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor. Blood (2024)
Warren Fiskus, Jessica Piel, Michael P Collins, Murphy Hentemann, Branko Cuglievan, Christopher P Mill, Christine Birdwell, Kaberi Das, John A Davis, Hanxi Hou, Antrix Jain, Anna Malovannaya, Tapan M Kadia, Naval G Daver, Koiji Sasaki, Koichi Takahashi, Danielle Hammond, Patrick K Reville, Jian Wang, Sanam Loghavi, Rwik Sen, Xinjia Ruan, Xiaoping Su, Lauren B Flores, Courtney D D DiNardo, Kapil N Bhalla
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor. Blood (2024)
Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li, Juan José Rodríguez Sevilla, Sangeetha Venugopal, Samuel Urrutia Argueta, Guillermo Montalban Bravo, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Rashmi Kanagal-Shamana, Irene Gañán-Gómez, Tapan Mahendra Kadia, Gautam Borthakur, Courtney D D DiNardo, Naval G Daver, Elias J Jabbour, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia Manero
Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li, Juan José Rodríguez Sevilla, Sangeetha Venugopal, Samuel Urrutia Argueta, Guillermo Montalban Bravo, Koiji Sasaki, Kelly Sharon Chien, Danielle Hammond, Rashmi Kanagal-Shamana, Irene Gañán-Gómez, Tapan Mahendra Kadia, Gautam Borthakur, Courtney D D DiNardo, Naval G Daver, Elias J Jabbour, Farhad Ravandi, Hagop M Kantarjian, Guillermo Garcia Manero
Cytogenetic and molecular associations with outcomes in HR-MDS treated with hypomethylating agents plus venetoclax. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Warren C Fiskus, Jessica Piel, Michael P Collins, Murphy Hentemann, Branko Cuglievan, Christopher P Mill, Christine E Birdwell, Kaberi Das, John A Davis, Hanxi Hou, Antrix Jain, Anna Malovannaya, Tapan M Kadia, Naval G Daver, Koiji Sasaki, Koichi Takahashi, Danielle Hammond, Patrick K Reville, Jian Wang, Sanam Loghavi, Rwik Sen, Xinjia Ruan, Xiaoping Su, Lauren B Flores, Courtney D D DiNardo, Kapil N Bhalla
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor. Blood 143 (20) (2024)
Guillermo Montalban Bravo, Juan Jose Rodriguez-Sevilla, David Michael Swanson, Rashmi Kanagal-Shamana, Danielle Hammond, Kelly Sharon Chien, Koiji Sasaki, Elias J Jabbour, Courtney D D DiNardo, Koichi Takahashi, Nicholas James Short, Ghayas C Issa, Naveen Pemmaraju, Tapan Mahendra Kadia, Farhad Ravandi, Naval G Daver, Gautam Borthakur, Sanam Loghavi, Sherry Pierce, Carlos Bueso-Ramos, Hagop M Kantarjian, Guillermo Garcia Manero
Influence of co-mutational patterns in disease phenotype and clinical outcomes of chronic myelomonocytic leukemia. Leukemia (2024)
Warren C Fiskus, Jessica Piel, Michael P Collins, Murphy Hentemann, Branko Cuglievan, Christopher P Mill, Christine E Birdwell, Kaberi Das, John A Davis, Hanxi Hou, Antrix Jain, Anna Malovannaya, Tapan M Kadia, Naval G Daver, Koiji Sasaki, Koichi Takahashi, Danielle Hammond, Patrick K Reville, Jian Wang, Sanam Loghavi, Rwik Sen, Xinjia Ruan, Xiaoping Su, Lauren B Flores, Courtney D D DiNardo, Kapil N Bhalla
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or menin inhibitor. Blood 143 (20) (2024)
Alex Bataller, Georgina Gener-Ricos, Emmanuel Almanza, Kelly Sharon Chien, Samuel Urrutia, Alexandre Bazinet, Juan Jose Rodriguez-Sevilla, Danielle Hammond, Koiji Sasaki, Koichi Takahashi, Courtney D D DiNardo, Farhad Ravandi, Gautam Borthakur, Tapan M Kadia, Rashmi Kanagal-Shamana, Hagop M Kantarjian, Guillermo Garcia-Manero, Guillermo Montalban Bravo
Therapy-related chronic myelomonocytic leukemia does not have the high-risk features of a therapy-related neoplasm. Blood advances (2024)
Danielle Hammond, Sanam Loghavi, Sa A Wang, Marina Y Konopleva, Tapan Mahendra Kadia, Naval G Daver, Maro Ohanian, Ghayas C Issa, Yesid Alvarado, Nicholas James Short, Koji Sasaki, Naveen Pemmaraju, Guillermo Montalban-Bravo, Curtis A Lachowiez, Abhishek Maiti, Guillermo Garcia Manero, Elias J Jabbour, Gautam Borthakur, Farhad Ravandi, Koichi Takahashi, Sherry R Pierce, Hagop M Kantarjian, Courtney D D DiNardo
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents. Blood cancer journal 13 (1) (2023)